| 产品详情 |
| Edit |   |
|---|
| Product Name | AP 24534 |
|---|
| Description | Potent multi-kinase and pan-Bcr-Abl inhibitor. Displays potent activity against cell lines expressing native Bcr-Abl or Bcr-AblT3151 (IC50 values are 0.37 and 2.0 nM respectively); also inhibits other Abl kinase domain mutants at nanomolar potencies. Exhibits inhibitory activity against PDGFRα, c-Src and c-Kit (IC50 values are 1.1, 5.4 and 12.5 nM respectively); potently inhibits FGFR and VEGFR family kinases. Orally active. Purity 98%. MW (observed): 532.56 |
|---|
| Size | 50 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-benzamide. Ponatinib |
|---|
| Gene, Accession, CAS # | CAS: 943319-70-8 |
|---|
| Catalog # | 4274/50 |
|---|
| Price | |
|---|
| Order / More Info | AP 24534 from TOCRIS BIOSCIENCE
|
|---|
| Product Specific References | PubMed: 23114643, 25046000 |
|---|
| 产品资料 |
|
|